loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Yatharth Hospital & Trauma Care Services Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Yatharth Hospital & Trauma Care Services Ltd. 25 May 2026 14:59 PM

Q4FY26 & FY26 Result Announced for Yatharth Hospital & Trauma Care Services Ltd.

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • Revenue from Operations: For Q4FY26, revenue stood at Rs 3,415.63 million, representing a YoY growth of 46.58% from Rs 2,330.27 million in Q4FY25 and a QoQ increase of 6.29% from Rs 3,213.60 million in Q3FY26. For the full year FY26, revenue reached Rs 12,071.72 million, up 36.31% from Rs 8,856.21 million in FY25.
  • Total Income: The Group reported a total income of Rs 3,486.71 million in Q4FY26, compared to Rs 2,371.22 million in Q4FY25 (YoY increase of 47.04%) and Rs 3,282.96 million in Q3FY26 (QoQ increase of 6.21%). Annual total income for FY26 was Rs 12,329.59 million versus Rs 8,966.62 million in FY25.
  • EBITDA: EBITDA for Q4FY26 reached a record high of Rs 799 million, growing 37% YoY from Rs 583 million. For the full year FY26, EBITDA stood at Rs 2,921 million, a 30% increase from Rs 2,254 million in FY25.
  • EBITDA Margin: The EBITDA margin for Q4FY26 was 23.4% compared to 25.0% in Q4FY25. For FY26, the margin was 24.2% compared to 25.4% in FY25.
  • Profit After Tax (PAT): PAT for Q4FY26 was Rs 446.98 million, a 15.43% YoY increase from Rs 387.23 million and a 3.75% QoQ increase from Rs 430.83 million. For the full year FY26, PAT stood at Rs 1,703.05 million, marking a 30.45% growth over Rs 1,305.50 million in FY25.

Standalone Financial Highlights:

  • Revenue from Operations: Standalone revenue for Q4FY26 was Rs 1,638.71 million, an increase of 45.65% YoY from Rs 1,125.07 million and 3.12% QoQ from Rs 1,589.18 million. For FY26, standalone revenue was Rs 5,918.84 million, up 29.66% from Rs 4,564.84 million in FY25.
  • Total Income: Total standalone income for Q4FY26 stood at Rs 1,706.35 million, compared to Rs 1,160.90 million in Q4FY25 and Rs 1,636.20 million in Q3FY26. Annual standalone income for FY26 was Rs 6,150.94 million.
  • Profit After Tax (PAT): Standalone PAT for Q4FY26 was Rs 237.56 million, up 8.50% YoY from Rs 218.96 million. For the full year FY26, standalone PAT was Rs 954.10 million compared to Rs 876.92 million in FY25, representing a YoY growth of 8.80%.

Business Highlights:

  • Hospital Performance and Expansion:
    • Newer hospitals in Greater Faridabad, Faridabad Sector-20, New Delhi, and Agra contributed Rs 753 million in revenues, accounting for 22% of the Group’s total revenues in Q4FY26.
    • Existing hospitals maintained strong momentum with a 29% YoY growth during the quarter.
    • The Group acquired a 300-bed hospital at Model Town, New Delhi, which commenced commercial operations on July 14, 2025.
    • Commercial operations at the 400-bed hospital in Sector 20, Faridabad, Haryana, began on September 22, 2025.
    • The Shantived hospital in Agra commenced operations on February 1, 2026, with a current capacity of 150 beds (expandable to 250 beds).
    • A binding and irrevocable term sheet has been signed to acquire an under-construction 250-bed hospital in Gurugram, expected to commence operations within the next twelve months.
  • Operating Metrics:
    • Group ARPOB (Average Revenue Per Occupied Bed) increased 5% YoY to Rs 33,283, driven by a higher share of high-value specialties.
    • Noida Extension and Greater Noida hospitals reported strong ARPOBs of Rs 47.8k and Rs 40.3k, respectively.
  • Financial Management:
    • Operating Cash Flows for FY26 stood at Rs 2,866 million with a 98% Cash Conversion Ratio.
    • Debtor days were successfully reduced to 112 days, compared to 125 days in the previous year.
  • Segment Performance: The company identifies ‘Medical and Healthcare Services’ as its only business revenue segment, operating solely within India.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals, said: “We are pleased to report a strong close to FY26, with Q4 delivering an industry-leading performance. The quarter and indeed the full year reflect our capabilities in not only acquiring newer hospitals, but also in integrating, scaling, and turning these assets into profitability. Our newer hospitals at Model Town (New Delhi), Faridabad Sector-20, and Agra have demonstrated a rapid scale-up, contributing meaningfully to the Group’s revenues within a short span of operations. The successful integration of the Agra facility has further strengthened our regional presence, while the Group’s entry into Gurugram with a 250-bed ultra-modern, high-end hospital enhances our positioning within the NCR market.”

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q3FY26 results

  • Revenue: Rs 3,205 million against Rs 2,192 million during Q3FY25, change 46%.
  • EBITDA: Rs 742 million against Rs 549 million during Q3FY25, change 35%.
  • EBITDA Margin: 23.2% for Q3FY26.
  • PAT: Rs 431 million against Rs 305 million during Q3FY25, change 41%.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals, said: “We are pleased to report an industry leading performance this quarter, with highest ever growth. This highlights our ability to successfully acquire, integrate, and scale new assetsrapidly. Our newly operationalised hospitals at Model Town, New Delhi and Faridabad Sec-20 contributed 9% to the Group’s revenues within their first full quarter of operations, driven 100% by Cash and TPA patients and 0% Government Business, supporting our strategic focus on improving payer mix. The Agra facility, integrated from February 2026, is expected to contribute meaningfully from this quarter. The Greater Faridabad hospital has turned profitable and is now adding significantly to Group financials, reflecting strong execution, brand recall, star doctor onboarding, and clinical excellence. With a strong execution engine in place, we remain confident of sustaining the accelerated growth and long-term value creation for all our stakeholders.”

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q2FY26 results

  • Operating Revenue at record Rs 2,794 million during the quarter, up 28% YoY.
  • EBITDA stood at a record Rs 645 million, up 18% YoY.
  • PAT at Rs 413 million, up by 33% YoY.
  • Net Cash Position as on Sep-25 stood at Rs 3,692 million.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are delighted to report another quarter of record revenues and EBITDA, driven by strong growth from our existing hospitals and the successful ramp-up of our new facilities. During the quarter, we operationalised our Model Town, Delhi and Faridabad hospitals, adding 700 beds, and acquired Shantived Hospital in Agra, adding ~250 beds. These milestones keep us ahead of schedule in achieving our bed expansion target.

We also strengthened governance by appointing MSKA & Associates (BDO International member firm) as our statutory auditor for Q2 financials and welcoming healthcare veteran Mr. Ramesh Krishnan as an independent director. Additionally, the Income Tax authorities have released provisional attachments of all properties and fixed deposits of the Company. We continue to prioritize strategic initiatives that deliver strong, sustainable growth and long-term stakeholder value.”

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q1FY26 results

  • Operating Revenue at Rs 2,578 million, up 22% YoY and 11% QoQ.
  • EBITDA at Rs 645 million, up 20% YoY and 13% QoQ, reflecting 13 consecutive quarters of EBITDA growth.
  • EBITDA margin improved 41 bps QoQ to 25.0%.
  • PAT at Rs 425 million, up by 40% YoY, despite higher depreciation led by capacity expansion.
  • Bed Occupancy increased to 65%, from 61% in Q1FY25.

Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are happy to report yet another quarter of consistent and robust growth at Yatharth Hospitals, marked by strong revenue performance and profitability growth in Q1FY26. This reflects our unwavering focus on operational excellence and disciplined expansion. With the Model Town and the Faridabad facility, having a combined capacity of 700 beds, we expect to further accelerate our growth momentum from Q2FY26 onwards. During the quarter, we successfully resolved the Jhansi-Orchha land issue, removing a key operational hurdle and paving the way for future development. We remain confident that these strategic initiatives will enable Yatharth Hospitals to sustain its growth trajectory and continue delivering long-term value to all stakeholders.”

Result PDF

Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Operating Revenue at Rs 2,318 million, up 30% YoY
  • Bed occupancy at 61%, compared to 57% in Q4 FY24
  • ARPOB at Rs 31,441, up 7% YoY
    • Noida Extension registers highest ARPOB at Rs 38.8k ( 11% YoY), followed by Greater Noida at Rs 35k ( 16% YoY)
  • EBITDA at Rs 570 million, up 23% YoY; EBITDA margin at 24.6%
  • PBT at Rs 485 million, up 10% YoY and 21% QoQ
  • PAT at Rs 387 million, up 1% YoY and 27% QoQ, due to lower taxes in the base year
  • Received possession of two upcoming hospitals – a 300 bed facility in Delhi and a ~400 bed facility in Faridabad – both of which are expected to become operational in Q1 FY26

FY25 Financial Highlights:

  • Operating Revenue at Rs 8,805 million, up 31% YoY
  • Bed occupancy at 61%, compared to 54% in FY24
    • Noida Extension and Jhansi-Orchha occupancy improves significantly to ~60% & 50% respectively in FY25, compared to 44% & 23% in FY24
  • ARPOB at Rs 30,829, up 8% YoY
    • Noida Extension ARPOB at Rs 38k, marking a 12% increase over FY24, while Greater Noida recorded an ARPOB of Rs 34.6k, reflecting a robust 20% YoY growth. These improvements reflect the effectiveness of the strategic focus on super-specialty services.
    • Faridabad achieves an ARPOB of Rs 31k
  • EBITDA at Rs 2,202 million, up 22% YoY; EBITDA margin at 25.0%, compared to 26.8% in the previous year, due to initial ramp-up costs associated with the newly operationalized Greater Faridabad facility
  • Depreciation increased to Rs 572 million, reflecting the expansion of our bed capacity and investment in advanced medical equipment across key hospitals
  • PAT at Rs 1,306 million, up 14% YoY; PAT margin at 14.8%
  • Net Cash position as on Mar-25 stood at Rs 5,032 million

Commenting on the performance, Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are pleased to report another quarter and year of robust growth at Yatharth Hospitals. Notably, our Operating Cash Flows were healthy at Rs 1,496 million in FY2025, with a cash conversion ratio of 68%, reflecting healthy profit to cash flows conversion. During the quarter, we received possession of our two newly acquired hospitals in New Delhi and Faridabad, adding approximately 300 and 400 beds, respectively, which are getting operationalise in Q1FY26. Looking ahead, we remain confident in our ability to sustain our growth trajectory, supported by significant investments in bed capacity expansion and advanced medical infrastructure.”

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app